Search

everythinglearnresearchcommunity

for

Search:↓

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

Fasting may reduce chemotherapy side effects.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Personalized treatment with inhibitors, minoxidil, and laser therapy helps hair loss.

CRISPR/Cas systems show promise for cancer treatment by targeting miRNAs, but delivery and specificity challenges remain.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Targeted cancer therapies can cause new side effects, requiring careful monitoring and management to ensure patient safety.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Using existing drugs for new treatments is cost-effective and safer.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Ayurvedic herbs may reduce side effects and improve effectiveness of cancer treatments.

Targeting colon cancer stem cells might lead to better treatment results.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Most adverse reactions to the treatment were mild, with nausea being the most common.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

More research is needed to understand chemotherapy-induced hair loss and its phases.

Applying the anti-cancer drug Bortezomib to skin can promote hair growth and increase hair proteins through the GATA-3 factor.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Chemotherapy can cause significant hair thinning and changes in hair texture, while tamoxifen has a smaller effect.

Lecithin-encapsulated resveratrol nanoparticles could be a safe and effective anti-cancer treatment.

Understanding phenotypic plasticity is crucial for developing effective cancer therapies.

Dutasteride is a safe and effective treatment for hair loss.

Superoxide dismutases help balance cell stress and may aid cancer treatment.